CD274 and nonpapillary renal cell carcinoma: Human endogenous retroviruses (hERVs) are also potential factors for predicting the efficacy of PD1/PD-L1 inhibitors, among which the expression of hERV 4700 is associated with a better response in ccRCC patients receiving aPD1 therapy [166].